Borocaptate-10B12 (sodium)
Borocaptate-10B12 (BSH-10B12) sodium is a boron-10 labeled Borocaptate (HY-142041) . Borocaptate sodium is a boron-containing compound that can be used as a therapeutic agent in boron neutron capture therapy (BNCT), exhibiting anticancer activity[1][2].
Product Specifications
CAS Number
[12448-24-7]
Product Name Alternative
BSH-10B12
UNSPSC
12352100
Hazard Statement
H315-H319-H335
Target
Biochemical Assay Reagents; Isotope-Labeled Compounds
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
S[10B]1234[10BH]567[10BH]189[10BH]2%10%11[10BH]3%12%13[10BH]45%14[10BH]6%15%16[10BH]78%17[10BH]%109%18[10BH]%12%11%19[10BH]%13%14%15[10BH]%16%17%19%18.[Na].[Na]
Molecular Formula
10B12H12Na2S
Molecular Weight
210.30
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501
References & Citations
[1]Bendel P, et al. Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH) : A comparison between and NMR[J]. Medical Physics, 2001, 28 (2) : 178-183. |[2]Kraft SL, et al. Borocaptate sodium: a potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors. Proc Natl Acad Sci U S A. 1992 Dec 15;89 (24) :11973-7.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
